Head_Type,Head_Entity,Relation,Tail_Type,Tail_Entity,Description
Biomarker,p-tau,is_measured_in,Clinical_Test,densely aligned CNT sensor array,p-tau通过密集排列的CNT传感器阵列进行测量
Disease,Alzheimer's disease,has_biomarker,Biomarker,Aβ 40,阿尔茨海默病的核心生物标志物之一是Aβ 40
Biomarker,Aβ 42/Aβ 40,is_used_for,Clinical_Test,densely aligned CNT sensor array,Aβ 42/Aβ 40比值用于密集排列的CNT传感器阵列的临床检测
Pathological_Change,neuritic plaques,composed_of,Protein,amyloid-β (Aβ) peptides,神经炎斑由淀粉样β肽组成
Disease,Alzheimer's disease,has_biomarker,Biomarker,p-tau,阿尔茨海默病的核心生物标志物之一是p-tau
Clinical_Test,CNT sensor array,detects,Biomarker,p-tau 181,CNT传感器阵列用于检测p-tau 181
Clinical_Test,densely aligned CNT sensor array,measures,Biomarker,t-tau,密集排列的CNT传感器阵列用于测量t-tau的浓度
Clinical_Test,CNT sensor array,has_sensitivity,Clinical_Manifestation,AD diagnosis,CNT传感器阵列在AD诊断中的平均敏感性为90.0%
Biomarker,p-tau 181/Aβ 42,higher_in,Disease,Alzheimer's disease,AD患者血浆中p-tau 181/Aβ 42的比值显著高于正常对照组
Clinical_Test,densely aligned CNT sensor array,measures,Biomarker,Aβ 40,密集排列的CNT传感器阵列用于测量Aβ 40的浓度
Biomarker,p-tau 181/Aβ 42,used_for,Disease,Alzheimer's disease,p-tau 181/Aβ 42比值用于区分阿尔茨海默病患者和健康对照组
Clinical_Test,CNT sensor array,detects,Biomarker,Aβ 40,CNT传感器阵列用于检测Aβ 40
Disease,Alzheimer's disease,has_biomarker,Biomarker,Aβ 42,阿尔茨海默病的核心生物标志物之一是Aβ 42
Disease,Alzheimer's disease,has_biomarker,Biomarker,t-tau,阿尔茨海默病的核心生物标志物之一是t-tau
Clinical_Test,densely aligned CNT sensor array,measures,Biomarker,Aβ 42,密集排列的CNT传感器阵列用于测量Aβ 42的浓度
Research_Method,densely aligned CNT sensor array,detects,Biomarker,AD core biomarkers,密集排列的碳纳米管传感器阵列用于检测阿尔茨海默病核心生物标志物
Clinical_Test,densely aligned CNT sensor array,has_accuracy,Clinical_Manifestation,diagnostic accuracy,密集排列的CNT传感器阵列的诊断准确率约为88.6%
Clinical_Test,densely aligned CNT sensor array,has_accuracy,Clinical_Manifestation,distinguishing accuracy,密集排列的CNT传感器阵列区分阿尔茨海默病患者和健康对照组的准确率约为90.2%
Clinical_Test,CNT sensor array,detects,Biomarker,t-tau,CNT传感器阵列用于检测t-tau
Pathological_Change,neurofibrillary tangles,composed_of,Protein,tau protein,神经纤维缠结由tau蛋白组成
Biomarker,Aβ 40,similar_in,Disease,Alzheimer's disease,AD患者和正常对照组血浆中Aβ 40的浓度相似
Biomarker,Aβ 42,higher_in,Disease,Alzheimer's disease,AD患者血浆中Aβ 42的浓度显著高于正常对照组
Biomarker,t-tau/Aβ 42,higher_in,Disease,Alzheimer's disease,AD患者血浆中t-tau/Aβ 42的比值显著高于正常对照组
Biomarker,Aβ 42,associated_with,Disease,Alzheimer's disease,Aβ 42蛋白与阿尔茨海默病相关
Biomarker,Aβ 42/Aβ 40,higher_in,Disease,Alzheimer's disease,AD患者血浆中Aβ 42/Aβ 40的比值显著高于正常对照组
Biomarker,t-tau/Aβ 42,increases_before,Clinical_Stage,clinical symptoms,t-tau/Aβ 42比值在临床症状出现前15年开始显著增加
Biomarker,Aβ 42,decreases_before,Clinical_Stage,clinical symptoms,Aβ 42水平在临床症状出现前约10年开始下降
Biomarker,Aβ 40,is_measured_in,Clinical_Test,densely aligned CNT sensor array,Aβ 40通过密集排列的CNT传感器阵列进行测量
Biomarker,t-tau,higher_in,Disease,Alzheimer's disease,阿尔茨海默病患者脑脊液中的t-tau蛋白浓度高于正常对照组
Biomarker,Aβ 42/Aβ 40,used_for,Disease,Alzheimer's disease,Aβ 42/Aβ 40比值用于区分阿尔茨海默病患者和健康对照组
Imaging_Method,neuroimaging,used_for,Disease,Alzheimer's disease,神经影像学用于阿尔茨海默病的诊断
Clinical_Test,CNT sensor array,detects,Biomarker,Aβ 42,CNT传感器阵列用于检测Aβ 42
Clinical_Test,CNT sensor array,has_selectivity,Clinical_Manifestation,AD diagnosis,CNT传感器阵列在AD诊断中的平均选择性为90.0%
Disease,Alzheimer's disease,affects,Population,people aged over 65 years,阿尔茨海默病影响65岁以上的人群
Biomarker,t-tau/Aβ 42,is_used_for,Clinical_Test,densely aligned CNT sensor array,t-tau/Aβ 42比值用于密集排列的CNT传感器阵列的临床检测
Biomarker,p-tau 181/Aβ 42,increases_before,Clinical_Stage,clinical symptoms,p-tau 181/Aβ 42比值在临床症状出现前15年开始显著增加
Biomarker,Aβ 40,associated_with,Disease,Alzheimer's disease,Aβ 40蛋白与阿尔茨海默病相关
Disease,Alzheimer's disease,has_biomarker,Biomarker,p-tau 181,阿尔茨海默病的生物标志物包括p-tau 181
Biomarker,p-tau 181,associated_with,Disease,Alzheimer's disease,p-tau 181蛋白与阿尔茨海默病相关
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,irreversible memory loss,阿尔茨海默病导致不可逆的记忆丧失
Disease,Alzheimer's disease,has_biomarker,Biomarker,Aβ 40,阿尔茨海默病的生物标志物包括Aβ 40
Disease,Alzheimer's disease,has_biomarker,Biomarker,t-tau,阿尔茨海默病的生物标志物包括t-tau
Biomarker,t-tau/Aβ 42,used_for,Disease,Alzheimer's disease,t-tau/Aβ 42比值用于区分阿尔茨海默病患者和健康对照组
Research_Method,multiplexed electrical sensing platform,detects,Biomarker,AD core biomarkers,多重电传感平台用于检测阿尔茨海默病核心生物标志物
Research_Method,ROC analysis,evaluates,Clinical_Test,CNT sensor array,ROC分析用于评估CNT传感器阵列的诊断准确性
Clinical_Test,densely aligned CNT sensor array,distinguishes,Disease,Alzheimer's disease,密集排列的CNT传感器阵列能够区分阿尔茨海默病患者和健康对照组
Disease,Alzheimer's disease,has_biomarker,Biomarker,Aβ 42,阿尔茨海默病的生物标志物包括Aβ 42
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,severe cognitive decline,阿尔茨海默病导致严重的认知衰退
Biomarker,t-tau,associated_with,Disease,Alzheimer's disease,t-tau蛋白与阿尔茨海默病相关
Biomarker,Aβ 42,lower_in,Disease,Alzheimer's disease,阿尔茨海默病患者脑脊液中的Aβ 42蛋白浓度低于正常对照组
Clinical_Test,neuropsychological tests,used_for,Disease,Alzheimer's disease,神经心理学测试用于阿尔茨海默病的诊断
Clinical_Test,CNT sensor array,has_accuracy,Clinical_Manifestation,AD diagnosis,CNT传感器阵列在AD诊断中的平均准确率为88.6%
Biomarker,t-tau,is_measured_in,Clinical_Test,densely aligned CNT sensor array,t-tau通过密集排列的CNT传感器阵列进行测量
Clinical_Test,densely aligned CNT sensor array,measures,Biomarker,p-tau,密集排列的CNT传感器阵列用于测量p-tau的浓度
Biomarker,p-tau/Aβ 42,is_used_for,Clinical_Test,densely aligned CNT sensor array,p-tau/Aβ 42比值用于密集排列的CNT传感器阵列的临床检测
Biomarker,Aβ 42,is_measured_in,Clinical_Test,densely aligned CNT sensor array,Aβ 42通过密集排列的CNT传感器阵列进行测量
